Key result
Ablation of cardiac myosin binding protein-C in mice attenuated the length-dependent increase in myofilament Ca2+-sensitivity and blunted changes in cross-bridge cycling kinetics.
Absolute Event Rate: 5.8% vs 5.71%
p-value: p=<0.05
Cardiac myosin binding protein-C (cMyBP-C) is an important regulator of length-dependent activation in the myocardium, as its ablation blunts length-dependent changes in cross-bridge kinetics.
Supports cMyBP-C role in length-dependent activation in mice; leaves open translation to human myocardial disease or therapy.
Enhanced cardiac contractile function with increased sarcomere length (SL) is, in part, mediated by a decrease in the radial distance between myosin heads and actin. The radial disposition of myosin heads relative to actin is modulated by cardiac myosin binding protein-C (cMyBP-C), suggesting that cMyBP-C contributes to the length-dependent activation (LDA) in the myocardium. However, the precise roles of cMyBP-C in modulating cardiac LDA are unclear. To determine the impact of cMyBP-C on LDA, we measured isometric force, myofilament Ca(2+)-sensitivity (pCa50) and length-dependent changes in kinetic parameters of cross-bridge (XB) relaxation (k rel), and recruitment (k df) due to rapid stretch, as well as the rate of force redevelopment (k tr) in response to a large slack-restretch maneuver in skinned ventricular multicellular preparations isolated from the hearts of wild-type (WT) and cMyBP-C knockout (KO) mice, at SL's 1.9 μm or 2.1 μm. Our results show that maximal force was not significantly different between KO and WT preparations but length-dependent increase in pCa50 was attenuated in the KO preparations. pCa50 was not significantly different between WT and KO preparations at long SL (5.82 ± 0.02 in WT vs. 5.87 ± 0.02 in KO), whereas pCa50 was significantly different between WT and KO preparations at short SL (5.71 ± 0.02 in WT vs. 5.80 ± 0.01 in KO; p < 0.05). The k tr, measured at half-maximal Ca(2+)-activation, was significantly accelerated at short SL in WT preparations (8.74 ± 0.56 s(-1) at 1.9 μm vs. 5.71 ± 0.40 s(-1) at 2.1 μm, p < 0.05). Furthermore, k rel and k df were accelerated by 32% and 50%, respectively at short SL in WT preparations. In contrast, k tr was not altered by changes in SL in KO preparations (8.03 ± 0.54 s(-1) at 1.9 μm vs. 8.90 ± 0.37 s(-1) at 2.1 μm). Similarly, KO preparations did not exhibit length-dependent changes in k rel and k df. Collectively, our data implicate cMyBP-C as an important regulator of LDA via its impact on dynamic XB behavior due to changes in SL.
No takes yet. Share an insight, caveat, or question.
Mamidi et al. (2014) studied cMyBP-C ablation. cMyBP-C knockout vs. Wild-type was evaluated on Myofilament Ca2+-sensitivity (pCa50) at short sarcomere length (1.9 μm) (p=<0.05). Ablation of cardiac myosin binding protein-C in mice attenuated the length-dependent increase in myofilament Ca2+-sensitivity and blunted changes in cross-bridge cycling kinetics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: